Evally
Start free
Research & data

Systematic review screener

Screen abstracts against your inclusion and exclusion criteria, one criterion at a time.

Title-and-abstract screening for systematic reviews: population, intervention, study design and outcome each checked against your criteria, exclusions applied, and anything uncertain sent to full-text review instead of silently dropped.

Use this judgeCustomize it

Screening support for researchers. Report it as a screening aid in your methods and have a person check a sample of both inclusions and exclusions.

Try it live

Real calls to Jev. Pick an example or paste your own.

Examples
205
245
No verdict yet

Pick an example or paste your own input, then run it.

Under the hood

Every question and rule, in the open. Fork it to change any of them.

What it asks

Reads criteria and abstract, then asks 5 questions in one call.

  1. Q1PopulationYes / no

    Does the study in the abstract match the population in the criteria?

  2. Q2InterventionYes / no

    Does the study test the intervention or exposure the criteria specify?

  3. Q3Study designYes / no

    Is the study design one the criteria allow?

  4. Q4OutcomeYes / no

    Does the study report an outcome the criteria require?

  5. Q5Meets an exclusionYes / no

    Does the study meet any exclusion criterion in the criteria?

How it decides

Rules run in code, top to bottom. The first one that matches gives the verdict.

  1. 1
    If Meets an exclusion ≥ 0.7Exclude
  2. 2
    If Population < 0.3Exclude
  3. 3
    If Intervention < 0.3Exclude
  4. 4
    If Population ≥ 0.7 and Intervention ≥ 0.7 and Study design ≥ 0.7 and Outcome ≥ 0.7Include
  5. ·
    DefaultFull-text review

Call it from your code

Every template runs as-is with an API key, no setup: POST /api/v1/judges/paper-screener/run.

curl -X POST https://tryevally.com/api/v1/judges/paper-screener/run \  -H "Authorization: Bearer $EVALLY_API_KEY" \  -H "Content-Type: application/json" \  -d '{  "input": {    "criteria": "Include: randomized controlled trials in adults with type 2 diabetes comparing GLP-1 receptor agonists with placebo, reporting HbA1c. Exclude: animal studies, type 1 diabetes, trials shorter than 12 weeks.",    "abstract": "Semaglutide versus placebo in adults with type 2 diabetes: a 26-week randomized, double-blind trial. 388 adults were randomized. The primary outcome was change in HbA1c from baseline, which fell by 1.4% with semaglutide versus 0.3% with placebo."  }}'

Seen in the wild

Community builds on Jev that use this pattern. Not affiliated with Evally.

More in Research & data